Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHAT | P28329 | 6/20 | 0.55 |
| ▸ | RXRA | P19793 | 1/20 | 0.53 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.53 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29563633 | 1.00 | CHAT (0.55) | CHATRXRAMTNR1AMTNR1BPTGS1 | |
| SCHEMBL272577 | 1.00 | CHAT (0.55) | CHATRXRAMTNR1AMTNR1BPTGS1 | |
| SCHEMBL1681129 | 1.00 | CHAT (0.55) | CHATRXRAMTNR1AMTNR1BPTGS1 | |
| SCHEMBL29693644 | 1.00 | CHAT (0.55) | CHATRXRAMTNR1AMTNR1BPTGS1 | |
| SCHEMBL5478934 | 0.88 | HPRT1 (0.54) | CHATRXRAMTNR1AMTNR1BPTGS1 | |
| SCHEMBL10706687 | 0.85 | CHAT (0.62) | CHATRXRAMTNR1AMTNR1BPTGS1 | |
| SCHEMBL10706694 | 0.85 | CHAT (0.62) | CHATRXRAMTNR1AMTNR1BPTGS1 | |
| SCHEMBL10706700 | 0.85 | CHAT (0.62) | CHATRXRAMTNR1AMTNR1BPTGS1 | |
| SCHEMBL10437275 | 0.83 | CHAT (0.60) | CHATRXRAMTNR1AMTNR1BPTGS1 | |
| SCHEMBL10437274 | 0.83 | CHAT (0.60) | CHATRXRAMTNR1AMTNR1BPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014073003-A1 | SINGLE-STEP PROCESS FOR THE PREPARATION OF ARYL OLEFINS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-05-15 | — | — | WO | claimed |
| CN-111183134-B | Heterocyclic compound and organic light-emitting device comprising the same | LT素材株式会社 | 2025-05-09 | — | — | CN | disclosed |
| CN-119331025-A | Organic electroluminescent material and device | 环球展览公司 | 2025-01-21 | — | — | CN | disclosed |
| CN-114341143-B | Heterocyclic compound and organic light-emitting device using same | LT素材株式会社 | 2024-10-15 | — | — | CN | disclosed |
| CN-113939517-B | Heterocyclic compound and organic light-emitting element comprising same | LT素材株式会社 | 2024-08-13 | — | — | CN | disclosed |
| CN-113166171-B | Heterocyclic compound and organic light-emitting device comprising the same | LT素材株式会社 | 2024-05-14 | — | — | CN | disclosed |
| US-11935803-B2 | Resin composition, laminate, semiconductor wafer with resin composition layer, substrate for mounting semiconductor with resin composition layer and semiconductor device | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-03-19 | — | — | US | disclosed |
| US-11924979-B2 | Resin composition, laminate, semiconductor wafer with resin composition layer, substrate for mounting semiconductor with resin composition layer and semiconductor device | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-03-05 | — | — | US | disclosed |
| CN-117355530-A | Heterocyclic compound, organic light-emitting element comprising same, and composition for organic layer | LT素材株式会社 | 2024-01-05 | — | — | CN | disclosed |
| US-20230416266-A1 | 6,7-DIHYDRO-PYRANO[2,3-d]PYRIMIDINE INHIBITORS OF KRAS G12C MUTANT | MERCK SHARP & DOHME LLC | 2023-12-28 | — | — | US | disclosed |
| US-4773916-A | SPARK IGNITION WITH FUSED RING COMPOUNDS | UNION OIL COMPANY OF CALIFORNIA (US) | 1988-09-27 | — | — | US | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0267574-A2 | Heat resistant copolymer composition | Sumitomo Dow Limited (JP) | 1988-05-18 | — | — | EP | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
| US-4237306-A | ELECTROPHILIC REACTIONS WITH ALKYL ARYL KETONES TO PRODUCE METHYL ARYL ALKANOATES | EMERY INDUSTRIES, INC. (US) | 1980-12-02 | — | — | US | disclosed |
| US-4172955-A | REARRANGMENT OF A CINNAMALDEHYDE TO A PHENYLMALONDIALDEHYDE TETRAMETHYL DISACETAL | EMERY INDUSTRIES, INC. (US) | 1979-10-30 | — | — | US | disclosed |
| US-4069385-A | FROM AN OLEFIN AND AN ORGANIC PEROXIDE WITH COPPER-SCHIFF BASE COMPEX AS CATALYST | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1978-01-17 | — | — | US | disclosed |
| US-4067823-A | Thallium(III) reagents supported on montmorillonite clay minerals and oxythallation processes for utilizing same | EMERY INDUSTRIES, INC. (US) | 1978-01-10 | — | — | US | disclosed |
| US-3946081-A | OXIDATION CATALYSTS, GROUP V, VI, OR VII OXIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230416266-A1 | 6,7-DIHYDRO-PYRANO[2,3-d]PYRIMIDINE INHIBITORS OF KRAS G12C MUTANT | KRAS, NRAS, HRAS | CHAT 4851/4885RXRA 2558/4885MTNR1A 4214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.